Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Migraine Patch Product No Longer Available

By Oct 20, 2017

Zecuity, launched in September 2015, is a transdermal system that delivers a therapeutic dose via a single-use, battery-powered patch wrapped around the upper arm or thigh.

HCV Treatment With DAAs Reduces Liver Cancer Risk Significantly

By Oct 20, 2017

Study authors from the University of Washington, Seattle, and Veterans Affairs Puget Sound Healthcare System in Seattle sought to investigate whether HCV eradication with DAAs could lower the risk of liver cancer in patients.

IDSA: New Clinical Practice Guidelines on Infectious Diarrhea Management

By Oct 19, 2017

The expert panel states that for the majority of patients with diarrhea, diagnostic testing is unnecessary.

FDA Committee Supports Semaglutide Approval for Type 2 Diabetes

By Oct 19, 2017

The FDA Committee's positive recommendation was based on data from the global development program, SUSTAIN, which evaluated the safety and efficacy of once-weekly semaglutide.

FDA Approves Gene Therapy for Certain Types of Non-Hodgkin Lymphoma

By Oct 19, 2017

Yescarta, a CD19-directed genetically modified autologous T cell immunotherapy, is indicated for use in large B-cell lymphoma including diffuse large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma.

More Articles by Da Hee Han, PharmD